Table 3.
Summary for long-term outcomes of conventional implantable collamer lens implantation (spanning 10 years or more) and hole implantable collamer lens implantation (5 years or more) for myopia.
| Author | Year | Type | Period (years) | Eyes | Age (years) | MSE (D) | logMAR UDVA | logMAR CDVA | within ±1.0 D | Cataract |
|---|---|---|---|---|---|---|---|---|---|---|
| Moya et al. (1) | 2015 | ICL V3, V4 (non-hole) | 12 | 110 | 30.69 ± 5.59 | −16.90 ± 4.26 | 0.49 ± 0.25 | 0.22 ± 0.25 | 34.3% | 13.88% |
| Guber et al. (2) | 2016 | ICL V4 (non-hole) | 10 | 75 | 38.8 ± 9.2 | −11.4 ± 2.9 | 0.6, decimal | 1.0, decimal | 65.7% | 54.8% |
| Kocová et al. (3) | 2017 | ICL V4 (non-hole) | 10 | 40 | 28.28 ± 6.25 | −11.0 ± 4.45 | 1.0, decimal | 1.18, decimal | 75.0% | 12.5% |
| Nakamura et al. (4) | 2019 | ICL V4 (non-hole) | 10 | 70 | 36.2 ± 7.7 | −9.97 ± 2.29 | −0.01 ± 0.24 | −0.18 ± 0.07 | 87.1% | 10.5% |
| Choi et al. (5) | 2019 | ICL V4 (non-hole) | 10 | 110 | 30.3 ± 8.3 | −12.01 ± 3.70 | 0.13 ± 0.20 | 0.03 ± 0.07 | N.A. | 12.1% |
| Shimizu et al. (12) | 2016 | ICL V4c (hole) | 5 | 32 | 31.9 ± 7.5 | −7.54 ± 2.40 | −0.17 ± 0.14 | −0.24 ± 0.08 | 100% | 0% |
| Alfonso et al. (13) | 2019 | ICL V4c (hole) | 5 | 147 | 31.24 ± 5.4 | −9.20 ± 3.02 | 0.02 ± 0.08 | 0.02 ± 0.09 | 90.1% | 0% |
| Fernández-Vega-Cueto et al. (14) | 2021 | ICL V4c (hole) | 7 | 84 | 31.04 ± 4.89 | −9.35 ± 2.90 | 0.17 ± 0.23 | 0.02 ± 0.08 | 100% | 0% |
| Current | 2021 | ICL V4c, V5 (hole) | 8 | 177 | 35.9 ± 7.9 | −7.99 ± 3.33 | −0.07 ± 0.17 | −0.20 ± 0.09 | 93% | 1.7% |
ICL, implantable collamer lens; MSE, manifest spherical equivalent; D, diopter; logMAR, logarithm of the minimal angle of resolution; UDVA, uncorrected distance visual acuity; CDVA, corrected distance visual acuity.